On Jun 27, 2018 Utah Medical Products Inc (NASDAQ:UTMD) Shorts Strengthened By 11.62%

June 27, 2018 - By Alice Fox

During 2018 Q1 the big money sentiment decreased to 1.21. That’s change of 0.54, from 2017Q4’s 1.75. 8 investors sold all, 25 reduced holdings as Utah Medical Products, Inc. ratio dropped. 22 rose positions while 18 funds amassed positions. Funds hold 2.48 million shares thus 3.44% more from 2017Q4’s 2.40 million shares.
California State Teachers Retirement System owns 0% invested in Utah Medical Products, Inc. (NASDAQ:UTMD) for 5,166 shs. New Jersey-based Prudential Financial Inc has invested 0% in Utah Medical Products, Inc. (NASDAQ:UTMD). Ny State Teachers Retirement Systems holds 0% or 300 shs. Geode Ltd Liability reported 42,765 shs. Wells Fargo & Company Mn holds 22,286 shs. Savings Bank Of New York Mellon invested in 0% or 24,410 shs. Rhumbline Advisers accumulated 0% or 3,129 shs. Janney Montgomery Scott Llc has 4,143 shs for 0% of their capital. Cardinal Management holds 9,802 shs or 0.3% of its capital. Deutsche National Bank Ag owns 12,337 shs for 0% of their capital. 3,363 are owned by Rice Hall James And Assoc Limited Co. Dimensional Fund Limited Partnership holds 168,267 shs or 0.01% of its capital. Jpmorgan Chase And has invested 0% of its capital in Utah Medical Products, Inc. (NASDAQ:UTMD). Advisory Svcs Net Ltd Liability Co reported 0.03% stake. Ameritas Ptnrs Incorporated holds 296 shs or 0% of its capital.

Utah Medical Products, Inc. registered $4.97 million net activity with 0 insider purchases and 17 insider sales since February 2, 2018. On Thursday, February 22 CORNWELL KEVIN L had sold 1,095 shs worth $99,660. On Monday, May 7 PAYNE BARBARA A also sold $251,569 worth of Utah Medical Products, Inc. (NASDAQ:UTMD).

Utah Medical Products Inc (NASDAQ:UTMD) had an increase of its shares shorted by 11.62%. It was published in June by FINRA the 65,300 shares shorted on UTMD. The 58,500 previous shares are up with 11.62%. Former UTMD’s position will need 5 days to recover. It has 12,900 average volume. Float short on Utah Medical Products Inc is 2.05%.

Ticker’s shares touched $113.4 during the last trading session after 1.00% change.Currently Utah Medical Products, Inc. is uptrending after 57.69% change in last June 27, 2017. UTMD has also 6,392 shares volume. UTMD outperformed the S&P500 by 45.12%.

Utah Medical Products, Inc. develops, makes, and distributes medical devices for the healthcare industry worldwide.The company has $423.04 million market cap. It provides fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system.46.82 is the P/E ratio. The firm also offers umbilical vessel catheters; DIALY-NATE, a disposable peritoneal dialysis set; PALA-NATE, a silicone oral protection device; URI-CATH, a urinary drainage system; and MYELO-NATE, a lumbar sampling kit.

There’s a substantial Utah Medical Products, Inc. (NASDAQ:UTMD) news released by Benzinga.com. It’s a report titled: “Benzinga’s Daily Biotech Pulse: Biohaven Sells Right To Drug, Obseva To Sell Shares” on June 19, 2018.

Utah Medical Products, Inc. (NASDAQ:UTMD) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.